NEW YORK & SINGAPORE--(BUSINESS WIRE)--RegASK, the Agentic AI platform redefining regulatory intelligence and workflow orchestration, today announced its partnership with Veeva Systems, a leading provider of industry cloud solutions for the global life sciences industry. RegASK is joining the Veeva AI Partner Program to integrate with Veeva's Regulatory Information Management (RIM) system, enabling life sciences organizations to connect near-real-time regulatory signals with established complia.

Veeva Systems (VEEV) closed at $172.52 in the latest trading session, marking a -1.21% move from the prior day.

VEEV's strong Q4, expanding AI strategy and major life sciences partnerships fuel growth despite rising costs.

Veeva Systems is reiterated as a Buy, with the growth thesis now supported by traction across R&D, Quality, Commercial, and AI-driven solutions. R&D and Quality modules are gaining adoption among the top 20 biopharmas, broadening VEEV's customer base and cross-sell opportunities beyond core products. Vault CRM is driving stronger Commercial Solutions growth and acting as a catalyst for cross-selling adjacent products, increasing wallet share and customer stickiness.

Veeva (VEEV) reported earnings 30 days ago. What's next for the stock?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Veeva Systems is a top player in its corner of the cloud market and benefits from a competitive edge. The company's large addressable market and new AI-powered tools could help improve its results.

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks are HRB, SPWH, SERA, VEEV and WKHS.

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Barlow Wealth Partners LLC cut its holdings in Veeva Systems Inc. (NYSE: VEEV) by 31.3% in the undefined quarter, according to its most recent 13F filing with the SEC. The firm owned 37,089 shares of the technology company's stock after selling 16,908 shares during the quarter. Barlow Wealth Partners LLC's holdings in Veeva